Methods of specifically labeling nucleic acids using CRISPR/Cas9

Overview

Executive Statement:

A new genome analysis technique that uses guide RNA and Cas9 nickase to detect target nucleic acid sequences using fluorescent labeling.

Description:

The technology involves a method for sequence-specific labeling that can target repetitive regions in the genome. This method contacts genomic DNA with a guide RNA and Cas9 nickase to produce a single-strand break (nick) adjacent to the target sequence. A fluorescently labeled nucleotide is incorporated into the nicked DNA, which is then used to detect the target nucleic acid sequence. This technique can be used for genomic research, clinical diagnostics, identification of structural variants, repetitive region mapping, etc.

Market Applications

  • Clinical diagnostics for detecting and typing structural variations
  • Development of new genome editing tools and techniques
  • Genomic research and analysis
  • Clinical Diagnostics

Key Advantages

  • Allows for precise mapping of long-range de novo assembly contiguity and validation
  • Can target repetitive regions often lacking in restriction site motif
  • Capable of detecting specific structural variations, providing accurate breaking points
  • Offers a potential solution to sequence mis-assembly in complex, duplicated, and repetitive regions
  • Improved accuracy in detecting target nucleic acid sequence 
  • Creates a barcode of a portion of the genomic DNA

Problems Solved

  • Inadequate long-range de novo assembly contiguity 
  • Sequence mis-assembly in complex segmentally duplicated and repetitive regions
  • Detection and delineation of structural variations
  • Overcomes the limitation of being unable to target repetitive regions

Intellectual Property and Development Status

US Patent Issued #US10640810B2 - Methods of specifically labeling nucleic acids using CRISPR/Cas - Expires 2037

References

Nature Scientific Reports 2024: A long-read sequencing strategy with overlapping linkers on adjacent fragments (OLAF-Seq) for targeted resequencing and enrichment

Nucleic Acids Research 2015: CRISPR-CAS9 D10A nickase target-specific fluorescent labeling of double strand DNA for whole genome mapping and structural variation analysis

Commercialization Opportunities

 This invention is part of a larger portfolio of technologies available for licensing and commercialization TOOLS FOR GENOMIC APPLICATIONS POWERED BY CRISPR/CAS9 BASED DNA LABELING

Contact Information

For Intellectual Property and Licensing inquiries

Tanvi Muni, PhD

Licensing Manager,

Drexel Applied Innovation

Office of Research and Innovation

3250 Chestnut Street, Ste. 3010
Philadelphia, PA 19104

Phone:267-359-5640

Email:tanvi.muni@drexel.edu

Inventor information

Ming Xiao, PhD

Professor
School of Biomedical Engineering, Science and Health Systems

Phone:215-895-2690

Email:mx44@drexel.edu

Inventor Webpage

 

For Information, Contact:

  • Robert Mcgrath
  • Sr. Associate Vice Provost
  • Drexel University
  • 215-895-0303
  • rbm26@drexel.edu

Inventors:

Keywords: